Clinical Trial Detail

NCT ID NCT01960023
Title Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors National Surgical Adjuvant Breast and Bowel Project (NSABP)
Indications

colorectal cancer

Therapies

Cetuximab + Neratinib

Age Groups: adult

Additional content available in CKB BOOST